UBS Maintains a 'Neutral' on Bristol-Myers Squibb Co. (BMY); Brivanib Misses in HCC
Go back to UBS Maintains a 'Neutral' on Bristol-Myers Squibb Co. (BMY); Brivanib Misses in HCC| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.05 | 52 Week High | $77.12 | |||
| Open | $66.05 | 52 Week Low | $49.03 | |||
| Day High | $66.05 | P/E | 42.89 | |||
| Day Low | $66.05 | EPS | $1.54 | |||
| Volume | 26,657 | |||||
